Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study reports that patients with alopecia areata in the US incur significantly higher healthcare utilization and expenses, primarily driven by ambulatory and pharmacy costs, compared to matched controls.

This study estimated the economic burden of alopecia areata in Romania for 2022, finding costs of 46.289 million EUR for adult and 1.89 million EUR for pediatric cases.

In this study, researchers analyzed data from Spain to find that alopecia areata is more prevalent in adults, with a point prevalence of 0.44% in 2021; they also noted significant healthcare costs and comorbidities, highlighting an unmet treatment need given limited systemic treatment use.

This study reported that alopecia areata imposes a significant personal and national economic burden in Japan, with estimated total costs of 112.7 billion yen due largely to productivity loss.

Alopecia areata significantly strains healthcare and finances in the UAE, needing better management.